Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals.
Frederique PonchelLaurence DuquenneXuanxiao XieDiane CorscaddenFarag ShuweihdiKulveer MankiaL A TrouwPaul EmeryPublished in: RMD open (2022)
We confirm added value of multiple AutoAbs testing for identifying progressors to clinical disease, allowing more specific stratification for intervention studies.